These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 36012089)
21. The cost of severe haemophilia in Europe: the CHESS study. O'Hara J; Hughes D; Camp C; Burke T; Carroll L; Diego DG Orphanet J Rare Dis; 2017 May; 12(1):106. PubMed ID: 28569181 [TBL] [Abstract][Full Text] [Related]
22. Healthcare Costs Associated with an Adequate Intake of Sugars, Salt and Saturated Fat in Germany: A Health Econometrical Analysis. Meier T; Senftleben K; Deumelandt P; Christen O; Riedel K; Langer M PLoS One; 2015; 10(9):e0135990. PubMed ID: 26352606 [TBL] [Abstract][Full Text] [Related]
23. [Direct costs of diabetes mellitus in Germany: first estimation of the differences related to educational level]. Korber K; Teuner CM; Lampert T; Mielck A; Leidl R Gesundheitswesen; 2013 Dec; 75(12):812-8. PubMed ID: 24132596 [TBL] [Abstract][Full Text] [Related]
24. [Costs of illness for asthma and COPD in adults in Germany]. Kirsch F; Teuner CM; Menn P; Leidl R Gesundheitswesen; 2013 Jul; 75(7):413-23. PubMed ID: 23553190 [TBL] [Abstract][Full Text] [Related]
25. [Economic burden of Clostridium difficile enterocolitis in German hospitals based on routine DRG data]. Grube RF; Heinlein W; Scheffer H; Rathmayer M; Schepp W; Lohse AW; Stallmach A; Wilke MH; Lerch MM; Z Gastroenterol; 2015 May; 53(5):391-7. PubMed ID: 25965986 [TBL] [Abstract][Full Text] [Related]
27. Public health relevance of Graves' orbitopathy. Ponto KA; Merkesdal S; Hommel G; Pitz S; Pfeiffer N; Kahaly GJ J Clin Endocrinol Metab; 2013 Jan; 98(1):145-52. PubMed ID: 23185037 [TBL] [Abstract][Full Text] [Related]
28. The economic impact of smoking in Germany. Ruff LK; Volmer T; Nowak D; Meyer A Eur Respir J; 2000 Sep; 16(3):385-90. PubMed ID: 11028648 [TBL] [Abstract][Full Text] [Related]
29. Cost-of-illness of psoriasis - results of a German cross-sectional study. Jungen D; Augustin M; Langenbruch A; Zander N; Reich K; Strömer K; Thaci D; Purwins S; Radtke M; Gutknecht M J Eur Acad Dermatol Venereol; 2018 Jan; 32(1):174-180. PubMed ID: 28857297 [TBL] [Abstract][Full Text] [Related]
30. Projecting the economic burden of type 1 and type 2 diabetes mellitus in Germany from 2010 until 2040. Voeltz D; Vetterer M; Seidel-Jacobs E; Brinks R; Tönnies T; Hoyer A Popul Health Metr; 2024 Jul; 22(1):17. PubMed ID: 39026351 [TBL] [Abstract][Full Text] [Related]
31. The Economic Impact and Health-Related Quality of Life of Spinal Muscular Atrophy. An Analysis across Europe. Peña-Longobardo LM; Aranda-Reneo I; Oliva-Moreno J; Litzkendorf S; Durand-Zaleski I; Tizzano E; López-Bastida J Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32764338 [No Abstract] [Full Text] [Related]
32. [Productivity costs of rheumatoid arthritis in Germany. Cost composition and prediction of main cost components]. Merkesdal S; Huelsemann JL; Mittendorf T; Zeh S; Zeidler H; Ruof J Z Rheumatol; 2006 Oct; 65(6):527-34. PubMed ID: 16534538 [TBL] [Abstract][Full Text] [Related]
33. Cost-of-illness of melanoma in Europe - a modelling approach. Krensel M; Schäfer I; Augustin M J Eur Acad Dermatol Venereol; 2019 Mar; 33 Suppl 2():34-45. PubMed ID: 30811699 [TBL] [Abstract][Full Text] [Related]
34. [Direct costs for Parkinson's treatment in private neurology practices in Berlin]. Ehret R; Balzer-Geldsetzer M; Reese JP; Dodel I; Becker E; Christopher A; Friedrich H; Kraemer S; Lüer W; Müngersdorf M; Puzich R; Rohr A; Schultes-Platzek I; Siefjediers V; Tiel-Wilck K; Oertel WH; Dodel R Nervenarzt; 2009 Apr; 80(4):452-8. PubMed ID: 19252890 [TBL] [Abstract][Full Text] [Related]
35. The economic costs of overactive bladder in Germany. Klotz T; Brüggenjürgen B; Burkart M; Resch A Eur Urol; 2007 Jun; 51(6):1654-62; discussion 1662-3. PubMed ID: 17161521 [TBL] [Abstract][Full Text] [Related]
36. Costs and quality of life of multiple sclerosis in Austria. Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339 [TBL] [Abstract][Full Text] [Related]
37. Costs and quality of life for patients with multiple sclerosis in Belgium. Kobelt G Eur J Health Econ; 2006 Sep; 7 Suppl 2():S24-33. PubMed ID: 17318662 [TBL] [Abstract][Full Text] [Related]
38. Acute and long-term costs of 268 peripheral nerve injuries in the upper extremity. Bergmeister KD; Große-Hartlage L; Daeschler SC; Rhodius P; Böcker A; Beyersdorff M; Kern AO; Kneser U; Harhaus L PLoS One; 2020; 15(4):e0229530. PubMed ID: 32251479 [TBL] [Abstract][Full Text] [Related]
39. Social/economic costs and health-related quality of life in patients with cystic fibrosis in Europe. Chevreul K; Michel M; Brigham KB; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Péntek M; von der Schulenburg JM; Kanavos P; Persson U; Fattore G; Eur J Health Econ; 2016 Apr; 17 Suppl 1():7-18. PubMed ID: 27059622 [TBL] [Abstract][Full Text] [Related]
40. [Cost of illness of inflammatory bowel disease in Germany]. Schnorbach MT; Kruis W Z Gastroenterol; 2021 Nov; 59(11):1173-1188. PubMed ID: 32869213 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]